Abbott Gains FDA Clearance For Lab-Based Concussion Test

Abbott said it received the US FDA nod to run its blood-based test to assess patients for concussions on its Alinity i laboratory instrument. This will make the test more widely available in hospitals and laboratories in the US.

Alinity i Laboratory instrument
• Source: Abbott

Abbott announced on 7 March it received US Food and Drug Administration clearance for a laboratory-based blood test used in hospitals to help clinicians assess mild traumatic brain injuries (TBI) in about 18 minutes.

A negative result rules out the need for a computed tomography (CT) scan and potentially long wait times in the...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation